These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 17409158

  • 1. Biological and immunological relations among human parvovirus B19 genotypes 1 to 3.
    Ekman A, Hokynar K, Kakkola L, Kantola K, Hedman L, Bondén H, Gessner M, Aberham C, Norja P, Miettinen S, Hedman K, Söderlund-Venermo M.
    J Virol; 2007 Jul; 81(13):6927-35. PubMed ID: 17409158
    [Abstract] [Full Text] [Related]

  • 2. Parvovirus B19 viral loads in relation to VP1 and VP2 antibody responses in diagnostic blood samples.
    Beersma MF, Claas EC, Sopaheluakan T, Kroes AC.
    J Clin Virol; 2005 Sep; 34(1):71-5. PubMed ID: 15985386
    [Abstract] [Full Text] [Related]

  • 3. Quantitative analysis of neutralizing immune responses to human parvovirus B19 using a novel reverse transcriptase-polymerase chain reaction-based assay.
    Bostic JR, Brown KE, Young NS, Koenig S.
    J Infect Dis; 1999 Mar; 179(3):619-26. PubMed ID: 9952368
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The association of VP1 unique region protein in acute parvovirus B19 infection and anti-phospholipid antibody production.
    Tzang BS, Tsay GJ, Lee YJ, Li C, Sun YS, Hsu TC.
    Clin Chim Acta; 2007 Mar; 378(1-2):59-65. PubMed ID: 17169353
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. T-helper cell-mediated interferon-gamma, interleukin-10 and proliferation responses to a candidate recombinant vaccine for human parvovirus B19.
    Franssila R, Hedman K.
    Vaccine; 2004 Sep 09; 22(27-28):3809-15. PubMed ID: 15315862
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Generation of a parvovirus B19 vaccine candidate.
    Chandramouli S, Medina-Selby A, Coit D, Schaefer M, Spencer T, Brito LA, Zhang P, Otten G, Mandl CW, Mason PW, Dormitzer PR, Settembre EC.
    Vaccine; 2013 Aug 20; 31(37):3872-8. PubMed ID: 23827313
    [Abstract] [Full Text] [Related]

  • 16. Frequent infection with a viral pathogen, parvovirus B19, in rheumatic diseases of childhood.
    Lehmann HW, Knöll A, Küster RM, Modrow S.
    Arthritis Rheum; 2003 Jun 20; 48(6):1631-8. PubMed ID: 12794831
    [Abstract] [Full Text] [Related]

  • 17. Human parvovirus B19 serology and avidity using a combination of recombinant antigens enables a differentiated picture of the current state of infection.
    Pfrepper KI, Enders M, Motz M.
    J Vet Med B Infect Dis Vet Public Health; 2005 Jun 20; 52(7-8):362-5. PubMed ID: 16316402
    [Abstract] [Full Text] [Related]

  • 18. Purification and analysis of polyhistidine-tagged human parvovirus B19 VP1 and VP2 expressed in insect cells.
    Michel PO, Mäkelä AR, Korhonen E, Toivola J, Hedman L, Söderlund-Venermo M, Hedman K, Oker-Blom C.
    J Virol Methods; 2008 Sep 20; 152(1-2):1-5. PubMed ID: 18598721
    [Abstract] [Full Text] [Related]

  • 19. A synthetic parvovirus B19 capsid protein can replace viral antigen in antibody-capture enzyme immunoassays.
    Kock WC.
    J Virol Methods; 1995 Sep 20; 55(1):67-82. PubMed ID: 8576310
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.